EUR 1.02
(5.7%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -2.09 USD | N/A |
2022 | 0.21 USD | 0.0% |
2021 | 0.40 USD | N/A |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.17 USD | -989.74% |
2024 Q1 | -0.02 USD | 91.33% |
2023 Q3 | -0.18 USD | 81.82% |
2023 Q4 | - USD | 100.0% |
2023 Q2 | -0.99 USD | 63.33% |
2023 Q1 | -2.70 USD | 0.0% |
2022 Q3 | -0.06 USD | -19.22% |
2022 FY | - USD | 0.0% |
2022 Q2 | -0.05 USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
BioNTech SE | 3.87 EUR | 154.005% |
CureVac N.V. | -1.18 EUR | -77.119% |
Biotest Aktiengesellschaft | 3.21 EUR | 165.109% |
Biotest Aktiengesellschaft | 3.21 EUR | 165.109% |
BRAIN Biotech AG | -0.38 EUR | -450.0% |
Formycon AG | 4.76 EUR | 143.908% |
Heidelberg Pharma AG | -0.44 EUR | -375.0% |
Medigene AG | -0.66 EUR | -216.667% |